CONMED Corporation (CNMD)
USD 69.32
(-2.68%)
USD 69.32
(-2.68%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.46 Billion USD | -5.56% |
| 2022 | 1.55 Billion USD | 58.28% |
| 2021 | 980.58 Million USD | -5.95% |
| 2020 | 1.04 Billion USD | -2.07% |
| 2019 | 1.06 Billion USD | 50.61% |
| 2018 | 706.86 Million USD | -2.71% |
| 2017 | 726.52 Million USD | -2.92% |
| 2016 | 748.4 Million USD | 41.78% |
| 2015 | 527.87 Million USD | 2.12% |
| 2014 | 516.89 Million USD | 6.76% |
| 2013 | 484.18 Million USD | 1.41% |
| 2012 | 477.46 Million USD | 31.71% |
| 2011 | 362.52 Million USD | -9.19% |
| 2010 | 399.21 Million USD | 4.78% |
| 2009 | 380.98 Million USD | -4.74% |
| 2008 | 399.92 Million USD | 2.82% |
| 2007 | 388.94 Million USD | -7.66% |
| 2006 | 421.21 Million USD | -6.56% |
| 2005 | 450.77 Million USD | 6.1% |
| 2004 | 424.84 Million USD | 14.34% |
| 2003 | 371.56 Million USD | 4.61% |
| 2002 | 355.2 Million USD | -15.02% |
| 2001 | 417.97 Million USD | -6.9% |
| 2000 | 448.96 Million USD | -0.43% |
| 1999 | 450.9 Million USD | 0.96% |
| 1998 | 446.6 Million USD | 11.96% |
| 1997 | 398.9 Million USD | 3368.7% |
| 1996 | 11.5 Million USD | -74.1% |
| 1995 | 44.4 Million USD | 133.68% |
| 1994 | 19 Million USD | -4.04% |
| 1993 | 19.8 Million USD | 518.75% |
| 1992 | 3.2 Million USD | -25.58% |
| 1991 | 4.3 Million USD | -54.26% |
| 1990 | 9.4 Million USD | -18.97% |
| 1989 | 11.6 Million USD | 346.15% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.4 Billion USD | -3.49% |
| 2024 Q3 | 1.38 Billion USD | -1.49% |
| 2024 Q1 | 1.45 Billion USD | -0.76% |
| 2023 Q2 | 1.54 Billion USD | -1.6% |
| 2023 Q1 | 1.56 Billion USD | 1.01% |
| 2023 Q3 | 1.52 Billion USD | -0.85% |
| 2023 Q4 | 1.46 Billion USD | -4.16% |
| 2023 FY | 1.46 Billion USD | -5.56% |
| 2022 Q3 | 1.57 Billion USD | 12.61% |
| 2022 FY | 1.55 Billion USD | 58.28% |
| 2022 Q2 | 1.39 Billion USD | 40.47% |
| 2022 Q4 | 1.55 Billion USD | -1.5% |
| 2022 Q1 | 996.17 Million USD | 1.59% |
| 2021 Q3 | 998.4 Million USD | -1.87% |
| 2021 FY | 980.58 Million USD | -5.95% |
| 2021 Q1 | 1.02 Billion USD | -2.07% |
| 2021 Q2 | 1.01 Billion USD | -0.35% |
| 2021 Q4 | 980.58 Million USD | -1.79% |
| 2020 Q4 | 1.04 Billion USD | -1.64% |
| 2020 FY | 1.04 Billion USD | -2.07% |
| 2020 Q3 | 1.05 Billion USD | 1.05% |
| 2020 Q2 | 1.04 Billion USD | -0.03% |
| 2020 Q1 | 1.04 Billion USD | -1.44% |
| 2019 FY | 1.06 Billion USD | 50.61% |
| 2019 Q3 | 1.05 Billion USD | -0.46% |
| 2019 Q4 | 1.06 Billion USD | 0.67% |
| 2019 Q2 | 1.06 Billion USD | -0.5% |
| 2019 Q1 | 1.06 Billion USD | 51.06% |
| 2018 Q3 | 710.32 Million USD | -0.73% |
| 2018 FY | 706.86 Million USD | -2.71% |
| 2018 Q1 | 707.4 Million USD | -2.63% |
| 2018 Q2 | 715.54 Million USD | 1.15% |
| 2018 Q4 | 706.86 Million USD | -0.49% |
| 2017 Q4 | 726.52 Million USD | -5.83% |
| 2017 Q2 | 752.98 Million USD | 0.06% |
| 2017 Q1 | 752.5 Million USD | 0.55% |
| 2017 Q3 | 771.52 Million USD | 2.46% |
| 2017 FY | 726.52 Million USD | -2.92% |
| 2016 Q1 | 760.49 Million USD | 44.07% |
| 2016 Q3 | 746.54 Million USD | -1.65% |
| 2016 Q2 | 759.1 Million USD | -0.18% |
| 2016 FY | 748.4 Million USD | 41.78% |
| 2016 Q4 | 748.4 Million USD | 0.25% |
| 2015 Q2 | 511.29 Million USD | -0.46% |
| 2015 FY | 527.87 Million USD | 2.12% |
| 2015 Q1 | 513.65 Million USD | -0.63% |
| 2015 Q4 | 527.87 Million USD | 2.18% |
| 2015 Q3 | 516.62 Million USD | 1.04% |
| 2014 FY | 516.89 Million USD | 6.76% |
| 2014 Q4 | 516.89 Million USD | 0.02% |
| 2014 Q1 | 487.72 Million USD | 0.73% |
| 2014 Q2 | 495.17 Million USD | 1.53% |
| 2014 Q3 | 516.79 Million USD | 4.37% |
| 2013 Q3 | 491.69 Million USD | -1.34% |
| 2013 Q4 | 484.18 Million USD | -1.53% |
| 2013 Q2 | 498.35 Million USD | 2.67% |
| 2013 Q1 | 485.4 Million USD | 1.66% |
| 2013 FY | 484.18 Million USD | 1.41% |
| 2012 Q4 | 477.46 Million USD | -1.83% |
| 2012 FY | 477.46 Million USD | 31.71% |
| 2012 Q2 | 467.84 Million USD | -4.49% |
| 2012 Q1 | 489.83 Million USD | 35.12% |
| 2012 Q3 | 486.34 Million USD | 3.95% |
| 2011 Q3 | 389.43 Million USD | 1.56% |
| 2011 Q1 | 391.35 Million USD | -1.97% |
| 2011 Q2 | 383.45 Million USD | -2.02% |
| 2011 Q4 | 362.52 Million USD | -6.91% |
| 2011 FY | 362.52 Million USD | -9.19% |
| 2010 Q2 | 408.35 Million USD | 0.07% |
| 2010 Q4 | 399.21 Million USD | -5.67% |
| 2010 Q1 | 408.05 Million USD | 6.85% |
| 2010 Q3 | 423.18 Million USD | 3.63% |
| 2010 FY | 399.21 Million USD | 4.78% |
| 2009 FY | 380.98 Million USD | -4.74% |
| 2009 Q3 | 380.86 Million USD | 3.61% |
| 2009 Q4 | 381.89 Million USD | 0.27% |
| 2009 Q2 | 367.6 Million USD | -1.49% |
| 2009 Q1 | 373.18 Million USD | -6.69% |
| 2008 Q4 | 399.92 Million USD | -1.29% |
| 2008 Q3 | 405.14 Million USD | 0.28% |
| 2008 Q2 | 404.01 Million USD | -0.39% |
| 2008 FY | 399.92 Million USD | 2.82% |
| 2008 Q1 | 405.6 Million USD | 4.28% |
| 2007 Q4 | 388.94 Million USD | -3.57% |
| 2007 FY | 388.94 Million USD | -7.66% |
| 2007 Q1 | 418.25 Million USD | -0.7% |
| 2007 Q2 | 398.8 Million USD | -4.65% |
| 2007 Q3 | 403.34 Million USD | 1.14% |
| 2006 Q2 | 450.52 Million USD | -0.19% |
| 2006 Q3 | 456.8 Million USD | 1.39% |
| 2006 Q4 | 421.21 Million USD | -7.79% |
| 2006 FY | 421.21 Million USD | -6.56% |
| 2006 Q1 | 451.36 Million USD | 0.13% |
| 2005 Q2 | 416.04 Million USD | 0.49% |
| 2005 FY | 450.77 Million USD | 6.1% |
| 2005 Q4 | 450.77 Million USD | 7.6% |
| 2005 Q1 | 414.01 Million USD | -2.55% |
| 2005 Q3 | 418.95 Million USD | 0.7% |
| 2004 FY | 424.84 Million USD | 14.34% |
| 2004 Q1 | 346.61 Million USD | -6.72% |
| 2004 Q2 | 346.56 Million USD | -0.01% |
| 2004 Q3 | 395.64 Million USD | 14.16% |
| 2004 Q4 | 424.84 Million USD | 7.38% |
| 2003 FY | 371.56 Million USD | 4.61% |
| 2003 Q2 | 392.55 Million USD | 1.11% |
| 2003 Q1 | 388.24 Million USD | 9.3% |
| 2003 Q4 | 371.56 Million USD | -4.45% |
| 2003 Q3 | 388.85 Million USD | -0.94% |
| 2002 Q4 | 355.2 Million USD | 4.14% |
| 2002 Q1 | 411.73 Million USD | -1.49% |
| 2002 FY | 355.2 Million USD | -15.02% |
| 2002 Q2 | 346.21 Million USD | -15.91% |
| 2002 Q3 | 341.09 Million USD | -1.48% |
| 2001 FY | 417.97 Million USD | -6.9% |
| 2001 Q4 | 417.97 Million USD | -9.83% |
| 2001 Q3 | 463.53 Million USD | 4.91% |
| 2001 Q2 | 441.84 Million USD | -1.07% |
| 2001 Q1 | 446.61 Million USD | -0.52% |
| 2000 FY | 448.96 Million USD | -0.43% |
| 2000 Q2 | 447.25 Million USD | 0.24% |
| 2000 Q3 | 450.94 Million USD | 0.82% |
| 2000 Q4 | 448.96 Million USD | -0.44% |
| 2000 Q1 | 446.2 Million USD | -1.04% |
| 1999 Q2 | 431.7 Million USD | -1.82% |
| 1999 Q3 | 459.9 Million USD | 6.53% |
| 1999 Q4 | 450.9 Million USD | -1.96% |
| 1999 FY | 450.9 Million USD | 0.96% |
| 1999 Q1 | 439.7 Million USD | -1.55% |
| 1998 Q3 | 409.1 Million USD | 1.74% |
| 1998 Q4 | 446.6 Million USD | 9.17% |
| 1998 FY | 446.6 Million USD | 11.96% |
| 1998 Q1 | 405.4 Million USD | 1.63% |
| 1998 Q2 | 402.1 Million USD | -0.81% |
| 1997 Q4 | 398.9 Million USD | 2577.18% |
| 1997 FY | 398.9 Million USD | 3368.7% |
| 1997 Q1 | 15.3 Million USD | 33.04% |
| 1997 Q2 | 14.4 Million USD | -5.88% |
| 1997 Q3 | 14.9 Million USD | 3.47% |
| 1996 FY | 11.5 Million USD | -74.1% |
| 1996 Q1 | 17.3 Million USD | -61.04% |
| 1996 Q2 | 13.2 Million USD | -23.7% |
| 1996 Q3 | 11.6 Million USD | -12.12% |
| 1996 Q4 | 11.5 Million USD | -0.86% |
| 1995 FY | 44.4 Million USD | 133.68% |
| 1995 Q2 | 50 Million USD | 25.94% |
| 1995 Q3 | 46.9 Million USD | -6.2% |
| 1995 Q4 | 44.4 Million USD | -5.33% |
| 1995 Q1 | 39.7 Million USD | 108.95% |
| 1994 Q4 | 19 Million USD | 0.0% |
| 1994 Q1 | 20.2 Million USD | 2.02% |
| 1994 Q2 | 18.6 Million USD | -7.92% |
| 1994 Q3 | 19 Million USD | 2.15% |
| 1994 FY | 19 Million USD | -4.04% |
| 1993 Q4 | 19.8 Million USD | 12.5% |
| 1993 Q3 | 17.6 Million USD | 450.0% |
| 1993 Q1 | 3.2 Million USD | 0.0% |
| 1993 FY | 19.8 Million USD | 518.75% |
| 1993 Q2 | 3.2 Million USD | 0.0% |
| 1992 Q2 | 4.2 Million USD | 2.44% |
| 1992 Q4 | 3.2 Million USD | -40.74% |
| 1992 Q1 | 4.1 Million USD | -4.65% |
| 1992 FY | 3.2 Million USD | -25.58% |
| 1992 Q3 | 5.4 Million USD | 28.57% |
| 1991 Q2 | 4.5 Million USD | -61.86% |
| 1991 Q3 | 4.1 Million USD | -8.89% |
| 1991 FY | 4.3 Million USD | -54.26% |
| 1991 Q4 | 4.3 Million USD | 4.88% |
| 1991 Q1 | 11.8 Million USD | 25.53% |
| 1990 Q3 | 10.8 Million USD | -9.24% |
| 1990 Q1 | 12.1 Million USD | 4.31% |
| 1990 Q4 | 9.4 Million USD | -12.96% |
| 1990 FY | 9.4 Million USD | -18.97% |
| 1990 Q2 | 11.9 Million USD | -1.65% |
| 1989 Q3 | 9.6 Million USD | 0.0% |
| 1989 Q4 | 11.6 Million USD | 20.83% |
| 1989 FY | 11.6 Million USD | 346.15% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 95.737% |
| Allurion Technologies Inc. | 142.19 Million USD | -930.808% |
| Artivion, Inc. | 510.61 Million USD | -187.064% |
| Avanos Medical, Inc. | 456.1 Million USD | -221.377% |
| Butterfly Network, Inc. | 84.22 Million USD | -1640.42% |
| Butterfly Network, Inc. | 84.22 Million USD | -1640.42% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 58.802% |
| Boston Scientific Corporation | 15.6 Billion USD | 90.607% |
| Perspective Therapeutics, Inc. | 3.44 Million USD | -42399.246% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | 44.557% |
| Paragon 28, Inc. | 162.95 Million USD | -799.495% |
| Glaukos Corporation | 478.64 Million USD | -206.237% |
| Globus Medical, Inc. | 1.08 Billion USD | -34.709% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -1305.409% |
| Integer Holdings Corporation | 1.41 Billion USD | -3.72% |
| Medtronic plc | 39.56 Billion USD | 96.295% |
| Nevro Corp. | 330.31 Million USD | -343.763% |
| Owlet, Inc. | 73.79 Million USD | -1886.204% |
| Penumbra, Inc. | 377.36 Million USD | -288.434% |
| Vicarious Surgical Inc. | 21.89 Million USD | -6594.675% |
| Smith & Nephew plc | 4.77 Billion USD | 69.27% |
| Sonendo, Inc. | 49.74 Million USD | -2846.863% |
| STERIS plc | 4.74 Billion USD | 69.13% |
| Stryker Corporation | 21.31 Billion USD | 93.124% |
| Vapotherm, Inc. | 132.95 Million USD | -1002.511% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 83.729% |